ProPhase Labs Inc (NASDAQ: PRPH). Extremely important negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Minor negative changes in fundamentals have recently occurred for ProPhase Labs Inc (NASDAQ: PRPH). Negative developments: significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred. Positive development: the stock’s power rating rose above 70.
In light of these highly negative signals we are reviewing our current Overall Rating of B. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
PRPH’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a modest Value Builder.
ProPhase Labs has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. ProPhase Labs has a neutral Appreciation Score of 54 but a good Power Rating of 73, and the Positive Value Trend Rating results.
Recent Price Action
ProPhase Labs Inc (NASDAQ: PRPH) stock closed at $4.85 on 6/4/24 after a decline of -2.8%. However, exceptionally low trading volume at 24% of normal accompanied the decline. The stock has declined -4.0% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment